Brandon Capital key facts
- Brandon Capital is a venture capital firm based in 31 Queen Street with 18 tracked portfolio companies.
- Notable positions include Vaxxas, Pheon Therapeutics, AdvanCell.
- The team roster lists 4 people.
Brandon Capital portfolio at a glance
18 portfolio companies are on record for Brandon Capital, including Vaxxas, Pheon Therapeutics and AdvanCell.
12 of the 18 carry a recorded valuation.
Brandon Capital team
4 people are on record at Brandon Capital: 3 partners and 1 other. Senior names include Christopher Nave Ph.D (Co-Founding Partner), Henry Thompson Ph.D (Co-Founding Partner) and J. Leighton Read MD (Board Member). 4 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 18 recorded positions
- ·Watchlist + alerts for Brandon Capital's activity
Portfolio
18 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Vaxxas | — | ▮ | ▮ | ▮ |
| Pheon Therapeutics | — | ▮ | ▮ | ▮ |
| AdvanCell | — | ▮ | ▮ | ▮ |
+ 15 more companies · all 18, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Team
4 people on record — 4 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Brandon Capital
- What companies does Brandon Capital invest in?
- Brandon Capital has 18 recorded portfolio companies, including Vaxxas, Pheon Therapeutics, AdvanCell.